C16 Biosciences

Next-gen ingredients to decarbonize consumer products, starting w/…

New York, United States · Founded 2018 · $28.5M raised

Headquarters
New York, New York
Employees
11–50
Founded
2018
Business Model
B2B
Website
c16bio.com
Total Funding
$28.5M
Last Round
$4.5M GrantJan 2024
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.

Summary

C16 Biosciences is a Biotech company based in New York, United States, founded in 2018. It has raised $28.5M in total across 3 rounds, most recently a $4.5M Grant round in Jan 2024. Investors include Y Combinator, Bill & Melinda Gates Foundation and Breakthrough Energy Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Grant2024 (est.)
$4.5M

Sign up to see all 3 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

C16 Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/c16bio"><img src="https://indexed.vc/api/badge/company/c16bio" alt="C16 Biosciences on Indexed.vc" width="260" height="76" /></a>